[go: up one dir, main page]

IT1406221B1 - COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD - Google Patents

COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD

Info

Publication number
IT1406221B1
IT1406221B1 ITRM2010A000650A ITRM20100650A IT1406221B1 IT 1406221 B1 IT1406221 B1 IT 1406221B1 IT RM2010A000650 A ITRM2010A000650 A IT RM2010A000650A IT RM20100650 A ITRM20100650 A IT RM20100650A IT 1406221 B1 IT1406221 B1 IT 1406221B1
Authority
IT
Italy
Prior art keywords
triptofano
aspartico
nad
nutritional
vitamin
Prior art date
Application number
ITRM2010A000650A
Other languages
Italian (it)
Inventor
Morte Davide Della
Original Assignee
Mkpharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mkpharma Srl filed Critical Mkpharma Srl
Priority to ITRM2010A000650A priority Critical patent/IT1406221B1/en
Priority to EP11813401.4A priority patent/EP2651406A1/en
Priority to PCT/IB2011/055642 priority patent/WO2012080952A1/en
Publication of ITRM20100650A1 publication Critical patent/ITRM20100650A1/en
Application granted granted Critical
Publication of IT1406221B1 publication Critical patent/IT1406221B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITRM2010A000650A 2010-12-13 2010-12-13 COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD IT1406221B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITRM2010A000650A IT1406221B1 (en) 2010-12-13 2010-12-13 COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD
EP11813401.4A EP2651406A1 (en) 2010-12-13 2011-12-13 Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields
PCT/IB2011/055642 WO2012080952A1 (en) 2010-12-13 2011-12-13 Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2010A000650A IT1406221B1 (en) 2010-12-13 2010-12-13 COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD

Publications (2)

Publication Number Publication Date
ITRM20100650A1 ITRM20100650A1 (en) 2012-06-14
IT1406221B1 true IT1406221B1 (en) 2014-02-14

Family

ID=43737282

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2010A000650A IT1406221B1 (en) 2010-12-13 2010-12-13 COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD

Country Status (3)

Country Link
EP (1) EP2651406A1 (en)
IT (1) IT1406221B1 (en)
WO (1) WO2012080952A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3765010A2 (en) * 2018-03-13 2021-01-20 Nuchido Limited Treatment of diseases involving nad
WO2020230011A1 (en) * 2019-05-13 2020-11-19 Guglielmo Buonamici Human nutraceutical supplement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3006040B1 (en) * 2004-06-04 2017-11-22 Washington University Methods and compositions for treating neuropathies
AU2009282076A1 (en) * 2008-08-12 2010-02-18 Sirtris Pharmaceuticals, Inc. Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators

Also Published As

Publication number Publication date
EP2651406A1 (en) 2013-10-23
ITRM20100650A1 (en) 2012-06-14
WO2012080952A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
IL221160A (en) 1,2,4-triazine-3-amine derivatives, process for the preparation thereof and use thereof in the preparation of medicaments
SMT201600218B (en) BATTERY FOR USE AS PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS
HUE049886T2 (en) Formulations containing tumor-specific neoantigens for use in the treatment of tumors
IL221675B (en) Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
MX338515B (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors.
PL2731947T3 (en) Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
IL218113A0 (en) Stable liquid oily ready-to-use formulations, preparation thereof and use thereof
IL235923B (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
IL232325A0 (en) 18-methyl-6'7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
ZA201206360B (en) Solid composition for the oral administration of dyes and diagnostic use thereof
IL218137A (en) Derivatives of substituted 4-benzoamido benzoic acid, compositions comprising them and their use in the manufacture of medicaments
IL226094A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
LT2400943T (en) Cosmetic or pharmaceutical emulsion for the skin to be mixed just prior to use
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL249825A0 (en) Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations
EP2822561A4 (en) Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof
IL232115A0 (en) Pharmaceutical compositions comprising dgla and /or 15-hetre and methods of use thereof
EP2636666A4 (en) Trans-2-decenoic acid derivative and medicament containing same
ZA201402452B (en) Novel pyrimethanil formulations and uses thereof in the treatment of crops
IL225485A0 (en) System and preparations for increased transport of medicine through the cheek tissue in the oral cavity
BR112012016736A2 (en) composition, pharmaceutical formulation and use of composition "
IT1406221B1 (en) COMPOSITION CONTAINING RESVERATROL L / TRIPTOFANO ACID L / ASPARTICO AND VITAMIN B3 (NAD +) FOR THE USE IN NUTRITIONAL AND COSMETIC PHARMACEUTICAL FIELD
IL222642A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
PL2521727T3 (en) New benzoic pyrrolopyridine derivatives and their use for the treatment of parkinson's disease
HU1000352D0 (en) Salts of (di)nitroindoline derivatives and preparation and use thereof and compositions containing the same